Hepatology International

, Volume 2, Issue 3, pp 308–315

Hepatitis E vaccine

Review Article

DOI: 10.1007/s12072-008-9071-4

Cite this article as:
Aggarwal, R. & Jameel, S. Hepatol Int (2008) 2: 308. doi:10.1007/s12072-008-9071-4


Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2 billion people live in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant subunit vaccines based on the viral capsid protein. This review summarizes these efforts.


Hepatitis Hepatitis E HEV Vaccine 

Copyright information

© Asian Pacific Association for the Study of the Liver 2008

Authors and Affiliations

  1. 1.Department of GastroenterologySanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)LucknowIndia
  2. 2.Virology GroupInternational Centre for Genetic Engineering and Biotechnology (ICGEB)New DelhiIndia